Orchestra BioMed Holdings Inc. (OBIO) — Financial Flexibility Index
Orchestra BioMed Holdings Inc. (OBIO) has a Financial Flexibility Index of -0.22x as of June 2026. Free cash flow of $-19.08 Million (operating CF $-19.33 Million minus capex $254.00K) represents 0% of total liabilities ($86.28 Million). Check OBIO tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Orchestra BioMed Holdings Inc. Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Orchestra BioMed Holdings Inc. across 6 annual periods. For the full cash flow conversion analysis, see OBIO cash flow conversion.
Annual Financial Flexibility Index for Orchestra BioMed Holdings Inc. (2020–2025)
Year-by-year free cash flow to debt coverage for Orchestra BioMed Holdings Inc.. Explore cash flow to debt ratio of Orchestra BioMed Holdings Inc. to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.94x | $-48.47 Million | $-48.96 Million | $51.48 Million | ▲ +19.1% |
| 2024 | -1.16x | $-50.27 Million | $-50.56 Million | $43.22 Million | ▲ +31.4% |
| 2023 | -1.69x | $-46.05 Million | $-46.13 Million | $27.17 Million | ▼ -154.2% |
| 2022 | -0.67x | $-28.70 Million | $-29.29 Million | $43.04 Million | ▼ -195.1% |
| 2021 | -0.23x | $-19.16 Million | $-19.43 Million | $84.76 Million | ▲ +23.7% |
| 2020 | -0.30x | $-25.64 Million | $-26.18 Million | $86.63 Million | — |